Succinylcholine is best described as which type of neuromuscular blocker?

Succinylcholine is best described as which type of neuromuscular blocker?

• A. Depolarizing neuromuscular blocking agent
• B. Non-depolarizing neuromuscular blocking agent
• C. Gamma-aminobutyric acid agonist
• D. N-methyl-D-aspartate receptor antagonist

Answer: (A)

It acts at the neuromuscular junction as a depolarizing blocker. Succinylcholine binds to nicotinic acetylcholine receptors and mimics acetylcholine, causing an initial depolarization of the motor end plate that shows up as fasciculations. After this brief activation, the end plate remains depolarized and unresponsive to further stimulation, producing paralysis. Its effects are ultra-short because it is rapidly broken down by plasma cholinesterases. This is different from non-depolarizing blockers, which simply occupy the receptor without activating it, preventing acetylcholine from binding and causing paralysis without the initial depolarization. The other two options involve receptors in the central nervous system (GABA or NMDA receptors) and do not describe a neuromuscular blocker at the junction.

It acts at the neuromuscular junction as a depolarizing blocker. Succinylcholine binds to nicotinic acetylcholine receptors and mimics acetylcholine, causing an initial depolarization of the motor end plate that shows up as fasciculations. After this brief activation, the end plate remains depolarized and unresponsive to further stimulation, producing paralysis. Its effects are ultra-short because it is rapidly broken down by plasma cholinesterases. This is different from non-depolarizing blockers, which simply occupy the receptor without activating it, preventing acetylcholine from binding and causing paralysis without the initial depolarization. The other two options involve receptors in the central nervous system (GABA or NMDA receptors) and do not describe a neuromuscular blocker at the junction.